Research Article

Computational Approach to Identify Enzymes That Are Potential Therapeutic Candidates for Psoriasis

Table 1

Selected hub proteins in the protein interaction network constructed from upregulated genes.

Gene symbolRefseq IDFull name (enzyme number)Topological metrics

CDKN1ANP_000380.1Cyclin dependent kinase inhibitor 1Acentrality: 64419
RUVBL2NP_006657.1RuvB like 2 (3.6.4.12: DNA helicase)centrality: 50925
COPS6NP_006824.2COP9 constitutive photomorphogenic homolog subunit 6centrality:60596
EWSR1NP_001156757.1Ewing sarcoma breakpoint region 1centrality: 62682
FTSJ1NP_036412.1FtsJ homolog 1degree: 27
SFNNP_006133.114-3-3 sigmacentrality: 50372
GRB2NP_002077.1Grb2centrality: 397096
CCDC85CNP_001138467.1C14orf65 proteincentrality: 76862
EIF6NP_002203.1Eukaryotic translation initiation factor 6centrality: 61909
ARF6NP_001654.1ADP ribosylation factor 6centrality: 45220
NFKB1NP_001158884.1NFKB1degree: 18
PCNANP_002583.1Proliferating cell nuclear antigencentrality: 46316
PINX1NP_060354.4Pin2 interacting protein X1centrality: 51027
PSMA2NP_002778.1Proteasome subunit alpha type 2 (3.4.25.1: Proteasome endopeptidase complex) degree: 17
VDAC1NP_003365.1VDAC1degree: 18
ZAP70NP_001070.2ZAP70 (2.7.10.2: Nonspecific protein-tyrosine kinase)centrality: 50140
IKBKENP_001180250.1IKKE (2.7.11.10: I-kappa-B kinase)centrality: 412760